Title:
【発明の名称】虚血後腎不全の予防および処置並びに虚血腎臓の保護のためのAT1-レセプターアンタゴニスト
Document Type and Number:
Japanese Patent JPH11513395
Kind Code:
A
Abstract:
PCT No. PCT/EP96/04162 Sec. 371 Date Apr. 6, 1998 Sec. 102(e) Date Apr. 6, 1998 PCT Filed Sep. 24, 1996 PCT Pub. No. WO97/13513 PCT Pub. Date Apr. 17, 1997The compound (S)-N-(1-carboxy-2-methylprop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine (valsartan) of formula or a salt thereof, in particular a pharmaceutically acceptable salt thereof, can be used for treating (acute and chronic) postischemic renal failure and for protecting the ischemic kidney.
Inventors:
Fumke, Ulrich
Application Number:
JP51466897A
Publication Date:
November 16, 1999
Filing Date:
September 24, 1996
Export Citation:
Assignee:
Novartis Actien Gezel Shaft
International Classes:
A61K31/00; A61K31/41; A61K31/415; A61K31/4164; A61K31/4174; A61K31/4178; A61K31/4184; A61K31/4188; A61K31/437; A61K31/44; A61K31/4427; A61K31/443; A61K31/4433; C07D401/10; A61K31/4439; A61K31/455; A61K31/47; A61K31/4709; A61K31/472; A61K31/4725; A61K45/00; A61P9/10; A61P13/00; A61P13/12; C07D257/04; C07D401/14; C07D403/10; C07D405/06; C07D409/06; C07D471/04; (IPC1-7): A61K45/00; A61K31/00; A61K31/41; A61K31/415; A61K31/44; A61K31/47
Attorney, Agent or Firm:
Aoyama Ryo (2 outside people)